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Haemophilia A and haemophilia B are inherited bleeding disorders caused by deficiencies in 
blood clotting factor proteins. They are sex-linked recessive disorders that are usually 
transmitted from carrier mother to affected son. Factor VIII deficiency causes haemophilia 
A, which affects about one in 5,000 males, and factor IX deficiency causes haemophilia B, 
which affects about one in 30,000 males (Kliegman, 2011). In 2012 there were estimated to 
be 6,742 people with haemophilia in the UK, 6,035 in France, 4,660 in Germany, and 18,628 
in the USA (World Federation of Hemophilia, 2013). For people with haemophilia, 
spontaneous bleeding in joints, muscles and other soft tissues, as well as bleeding caused by 
injury or surgery, is not controlled by blood clotting, and repeated joint bleeds can damage 
the joints, leading to arthropathy, disability and chronic pain (Acharya, 2012).  
Trials of gene therapy treatment show encouraging preliminary results but also 
significant limitations (Nienhuis et al., 2016), and replacement clotting factor is currently the 
main treatment. Prophylaxis (preventative clotting factor treatment) can reduce bleeds and 
improve quality of life (Royal et al., 2002) but prophylaxis is expensive (Zhou et al., 2015) 
and 20%-30% of people with haemophilia A develop inhibitors, which make replacement 
clotting factors less effective (Tabriznia-Tabrizi et al., 2016). Physical activity is also 
important, and exercise can improve joints and mobility (Mulvany et al., 2010; Schäfer et al., 
2016). 
Life expectancy for people with haemophilia has improved but is still reduced 
(Mazepa et al., 2016). During the 1970s and 1980s, many people with haemophilia were 
infected with HIV and hepatitis C through contaminated clotting factor concentrates, and 
the organisation Tainted Blood was set up “to support and to achieve justice for those 
infected and affected by contaminated blood and blood products in the United Kingdom” 





infection showed considerable resilience in terms of adaptive behavior and emotional and 
behavioral problems (Nichols et al., 2000). 
Inheritance raises difficult family issues, and genetic carrier testing for haemophilia is 
generally not recommended for children, but parents in one study were happy to know the 
results even when they showed that a child was a carrier (Vears et al., 2016). An 
ethnographic study of families affected by haemophilia showed that the main effects were 
on family relationships, school, employment and travel (Khair et al., 2014). Prophylaxis 
facilitated more regular family routines in one study, but did not completely normalize 
family life (Emiliani et al., 2011).  
In other studies, behavioural techniques such as counterconditioning, distraction and 
differential positive reinforcement helped to improve a child’s adherence to clotting factor 
treatment (Penica & Williams, 2008), and motivation and autonomy were key factors in 
increasing self-care for children with haemophilia (Bérubé et al., 2016). Attention to 
children’s pain is important because qualitative research showed how pain affects children’s 
experiences of haemophilia and treatment (Spitzer, 1993). 
Physical quality of life is lower among adults with haemophilia than the general 
population, and lower among people with haemophilia who have more joint damage or are 
not treated with prophylaxis, but mental quality of life is less affected by haemophilia and 
less closely associated with joint status (Poon et al., 2012; Royal et al., 2002). Generic 
measures of quality of life, such as the SF-36, may not be specific or responsive enough to 
changes in health status (Szende et al., 2003), and there are haemophilia-specific measures 
of quality of life and subjective well-being (Remor et al., 2004; Remor, 2013). 
The impact of pain for people with haemophilia, especially in developing countries, is 
beginning to be more widely recognised (Humphries & Kessler, 2016), and in a study 
covering over 5,000 adults with haemophilia at treatment centres in Europe, 67% had 
arthropathy and 35% had chronic pain (Holstein et al., 2012). A survey in the USA showed 
that 39% of people with haemophilia believed their pain was not well treated and many 
reported using alcohol and illicit drugs to manage pain (Witkop et al., 2012). Acute bleeding 
pain should be treated promptly with replacement clotting factor but chronic joint pain 
should not, so it is important to distinguish chronic joint pain from acute bleeding pain, 
which some people with haemophilia may have difficulty doing (Witkop et al., 2011). 
In studies of the impact of pain on quality of life among people with haemophilia, 
pain intensity influenced physical quality of life and pain acceptance influenced mental 
quality of life, whereas active pain coping did not influence either physical or mental quality 
of life (Elander et al., 2009; Elander et al., 2013). In a DVD intervention to improve readiness 
to self-manage chronic joint pain caused by haemophilia, all the content was presented by 
five men with haemophilia who described their own experiences of living with joint pain, 





accordingly (Elander et al., 2011). Compared with a written information booklet, the DVD 
increased readiness to self-manage pain, and improved mental health-related quality of life 
among those with only high school education (Elander et al., 2011; Stalker & Elander, 2015).  
Evidence like this suggests that behavioural and psychological factors influence self-
management and quality of life in the same ways among people with haemophilia as among 
those with other chronic pain conditions, so there should be scope for interventions 
developed for other chronic pain conditions to be adapted for people with haemophilia, 
provided that careful account is taken of the need to respond promptly to acute bleeding 
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